517 related articles for article (PubMed ID: 20195007)
1. Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.
Stant AD; TenVergert EM; Kluiter H; Conradi HJ; Smit A; Ormel J
J Ment Health Policy Econ; 2009 Dec; 12(4):195-204. PubMed ID: 20195007
[TBL] [Abstract][Full Text] [Related]
2. Enhanced treatment for depression in primary care: long-term outcomes of a psycho-educational prevention program alone and enriched with psychiatric consultation or cognitive behavioral therapy.
Conradi HJ; de Jonge P; Kluiter H; Smit A; van der Meer K; Jenner JA; van Os TW; Emmelkamp PM; Ormel J
Psychol Med; 2007 Jun; 37(6):849-62. PubMed ID: 17376257
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of integrated care for elderly depressed patients in the PRISM-E study.
Wiley-Exley E; Domino ME; Maxwell J; Levkoff SE
J Ment Health Policy Econ; 2009 Dec; 12(4):205-13. PubMed ID: 20195008
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
[TBL] [Abstract][Full Text] [Related]
5. Are psychological treatments for depression in primary care cost-effective?
Bosmans JE; van Schaik DJ; de Bruijne MC; van Hout HP; van Marwijk HW; van Tulder MW; Stalman WA
J Ment Health Policy Econ; 2008 Mar; 11(1):3-15. PubMed ID: 18424872
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of a disease management program for major depression in elderly primary care patients.
Bosmans J; de Bruijne M; van Hout H; van Marwijk H; Beekman A; Bouter L; Stalman W; van Tulder M
J Gen Intern Med; 2006 Oct; 21(10):1020-6. PubMed ID: 16836625
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of improving primary care treatment of late-life depression.
Katon WJ; Schoenbaum M; Fan MY; Callahan CM; Williams J; Hunkeler E; Harpole L; Zhou XH; Langston C; Unützer J
Arch Gen Psychiatry; 2005 Dec; 62(12):1313-20. PubMed ID: 16330719
[TBL] [Abstract][Full Text] [Related]
8. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care.
King M; Sibbald B; Ward E; Bower P; Lloyd M; Gabbay M; Byford S
Health Technol Assess; 2000; 4(19):1-83. PubMed ID: 11086269
[TBL] [Abstract][Full Text] [Related]
9. Impact of primary care depression intervention on employment and workplace conflict outcomes: is value added?
Smith JL; Rost KM; Nutting PA; Libby AM; Elliott CE; Pyne JM
J Ment Health Policy Econ; 2002 Mar; 5(1):43-9. PubMed ID: 12529569
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
Simpson KN; Welch MJ; Kozel FA; Demitrack MA; Nahas Z
Adv Ther; 2009 Mar; 26(3):346-68. PubMed ID: 19330495
[TBL] [Abstract][Full Text] [Related]
12. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
13. Short-term effects of enhanced treatment for depression in primary care: results from a randomized controlled trial.
Smit A; Kluiter H; Conradi HJ; van der Meer K; Tiemens BG; Jenner JA; van Os TW; Ormel J
Psychol Med; 2006 Jan; 36(1):15-26. PubMed ID: 16356293
[TBL] [Abstract][Full Text] [Related]
14. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression.
Pyne JM; Fortney JC; Tripathi SP; Maciejewski ML; Edlund MJ; Williams DK
Arch Gen Psychiatry; 2010 Aug; 67(8):812-21. PubMed ID: 20679589
[TBL] [Abstract][Full Text] [Related]
16. Gender patterns in cost effectiveness of quality improvement for depression: results of a randomized, controlled trial.
Schoenbaum M; Sherbourne C; Wells K
J Affect Disord; 2005 Aug; 87(2-3):319-25. PubMed ID: 16005520
[TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness of short-term psychodynamic psychotherapy and solution-focused therapy in the treatment of depressive and anxiety disorders during a one-year follow-up.
Maljanen T; Paltta P; Harkanen T; Virtala E; Lindfors O; Laaksonen MA; Knekt P;
J Ment Health Policy Econ; 2012 Mar; 15(1):13-23. PubMed ID: 22611089
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of interpersonal psychotherapy for elderly primary care patients with major depression.
Bosmans JE; van Schaik DJ; Heymans MW; van Marwijk HW; van Hout HP; de Bruijne MC
Int J Technol Assess Health Care; 2007; 23(4):480-7. PubMed ID: 17937837
[TBL] [Abstract][Full Text] [Related]
19. Clinical effectiveness of individual cognitive behavioral therapy for depressed older people in primary care: a randomized controlled trial.
Serfaty MA; Haworth D; Blanchard M; Buszewicz M; Murad S; King M
Arch Gen Psychiatry; 2009 Dec; 66(12):1332-40. PubMed ID: 19996038
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of combination therapy versus antidepressant therapy for management of depression in Japan.
Sado M; Knapp M; Yamauchi K; Fujisawa D; So M; Nakagawa A; Kikuchi T; Ono Y
Aust N Z J Psychiatry; 2009 Jun; 43(6):539-47. PubMed ID: 19440886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
